Bobulsky Susan Insider Trades

Insider Trading History

Track insider trading activity for Bobulsky Susan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $7.73M 427,775 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$544k 41,338 shares
$13.17
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $8.48M 469,113 shares
Last Trade
Mar 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.03M 62,500 shares
$16.44
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $7.35M 406,613 shares
Last Trade
Mar 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$976k 59,375 shares
$16.44
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $6.28M 347,238 shares
Last Trade
Mar 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$209k 26,023 shares
$8.03
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $6.75M 373,261 shares
Last Trade
Mar 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.46M 180,029 shares
$8.12
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $0 0 shares
Last Trade
Oct 08, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.3k 5,000 shares
$5.25
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $4.58M 253,290 shares
Last Trade
Oct 08, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.3k 5,000 shares
$5.25
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $4.62M 255,265 shares
Last Trade
Mar 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$44.7k 12,991 shares
$3.44
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $4.72M 261,281 shares
Last Trade
Mar 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$796k 199,549 shares
$3.99
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Chief Commercial Officer, MRD
Holding Value $2.32M 128,302 shares
Last Trade
Jan 25, 2024 Sale
$269k 67,224 shares
$4.00
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $166k 9,158 shares
Last Trade
Mar 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 9,158 shares
$43.68
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $414k 22,894 shares
Last Trade
Mar 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1M 22,894 shares
$43.68
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $452k 25,000 shares
Last Trade
Dec 10, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.38M 25,000 shares
$55.23
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $0 0 shares
Last Trade
Dec 10, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.38M 25,000 shares
$55.00
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $542k 30,000 shares
Last Trade
Dec 10, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.38M 25,000 shares
$55.23
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $994k 55,000 shares
Last Trade
Sep 29, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$480k 10,000 shares
$48.04
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $181k 10,000 shares
Last Trade
Sep 29, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$480k 10,000 shares
$48.04
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $0 0 shares
Last Trade
Sep 29, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$500k 10,000 shares
$50.00
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $362k 20,000 shares
Last Trade
Aug 13, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$790k 20,000 shares
$39.50
$18.08
Adaptive Biotechnologies
Adaptive Biotechnologies ADPT
Svp, Diagnostics, Clonoseq
Holding Value $0 0 shares
Last Trade
Aug 06, 2020 Sale
$1.15M 28,750 shares
$40.09
$18.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up